Robert DuPont

Last updated
  1. 1 2 Institute for Behavior and Health, Inc. www.ibhinc.org
  2. Dupont, Robert L. (31 July 2018). Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic. ISBN   978-1985750326.
  3. Dupont, Robert (16 March 2000). The Selfish Brain: Learning from Addiction. ISBN   1-56838-363-0.
  4. Dupont, Robert L.; Brethen, Paul R.; Newel, Richard A. (2005). Drug Testing in Treatment Settings: Guidelines for Effective Use. ISBN   978-1-59285-179-9.
  5. Dupont, Robert L.; Brady, Lisa (2005). Drug Testing in Schools: Guidelines for Effective Use. ISBN   1-59285-180-0.
  6. Dupont, Robert L.; Mieczkowski, Thomas; Newel, Richard A. (2005). Drug Testing in Correctional Settings: Guidelines for Effective Use. ISBN   1-59285-181-9.
  7. Hazelden published works by Robert L. DuPont http://www.hazelden.org/OA_HTML/hazAuthor.jsp?author_id=156&item=8064
  8. American Society of Addiction Medicine. ASAM Fellows. Accessed November 6, 2009 http://www.asam.org/FellowList.html
  9. "Why Marijuana is the Most Dangerous Drug" . Retrieved 24 January 2014.
  10. "Alcohol most harmful drug based on multi-criteria analysis" . Retrieved 1 September 2015.
  11. PBS Frontline: Drug Wars. Interview with Dr. Robert DuPont 2000. Accessed November 6, 2009 https://www.pbs.org/wgbh/pages/frontline/shows/drugs/interviews/dupont.html
  12. Trebach (2005). The Great Drug War. ISBN   978-1588321183.
  13. Bensinger, DuPont & Associates www.bensingerdupont.com
  14. DuPont Clinical Research http://www.dupontclinicalresearch.com/
  15. DuPont, Robert L. (2008). "Addiction in medicine". Transactions of the American Clinical and Climatological Association. 119: 227–241. PMC   2394682 . PMID   18596844.
  16. "Biography: Robert L. DuPont, M.D.". Treasury, Postal Service, and General Government Appropriations for Fiscal Year 1975: Hearings, Ninety-third Congress, Second Session, Part 3. U.S. Printing Office. 1974. pp. 420–421.
Robert DuPont
Director of the Special Action Office for Drug Abuse Prevention
In office
June 17, 1973 June 30, 1975

Related Research Articles

<span class="mw-page-title-main">Codependency</span> Type of relationship where one person enables the others self-destructive tendencies

In psychology, codependency is a theory that attempts to explain imbalanced relationships where one person enables another person's self-destructive behavior such as addiction, poor mental health, immaturity, irresponsibility, or under-achievement.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

According to proponents of the concept, sexual addiction, also known as sex addiction, is a state characterized by compulsive participation or engagement in sexual activity, particularly sexual intercourse, despite negative consequences. The concept is contentious; neither of the two major mainstream medical categorization systems recognise sex addiction as a real medical condition, instead categorizing such behavior under labels such as compulsive sexual behavior.

A methadone clinic is a medical facility where medications for opioid use disorder (MOUD) are dispensed-—historically and most commonly methadone, although buprenorphine is also increasingly prescribed. Medically assisted drug therapy treatment is indicated in patients who are opioid-dependent or have a history of opioid dependence. Methadone is a schedule II (USA) opioid analgesic, that is also prescribed for pain management. It is a long-acting opioid that can delay the opioid withdrawal symptoms that patients experience from taking short-acting opioids, like heroin, and allow time for withdrawal management. In the United States, by law, patients must receive methadone under the supervision of a physician, and dispensed through an Opioid Treatment Program (OTP) certified by the Substance Abuse and Mental Health Services Administration and registered with the Drug Enforcement Administration.

<span class="mw-page-title-main">Rifaximin</span> Antibiotic medication

Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy. It acts by inhibiting RNA synthesis in susceptible bacteria by binding to the RNA polymerase enzyme. This binding blocks translocation, which stops transcription. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.

Marc Galanter is Professor of Psychiatry at New York University School of Medicine and has served as the Founding Director of the Division of Alcoholism and Drug Abuse. His studies have addressed family therapy for substance abuse, pharmacologic treatment for addiction, and Twelve Step recovery for addiction. He is an author of over 200 peer-reviewed articles. He chairs Twelve Step Interest Groups in AAAP, ASAM, and the International Society of Addiction Medicine and teaches at the New York University School of Medicine.

Addiction medicine is a medical subspecialty that deals with the diagnosis, prevention, evaluation, treatment, and recovery of persons with addiction, of those with substance-related and addictive disorders, and of people who show unhealthy use of substances including alcohol, nicotine, prescription medicine and other illicit and licit drugs. The medical subspecialty often crosses over into other areas, since various aspects of addiction fall within the fields of public health, psychology, social work, mental health counseling, psychiatry, and internal medicine, among others. Incorporated within the specialty are the processes of detoxification, rehabilitation, harm reduction, abstinence-based treatment, individual and group therapies, oversight of halfway houses, treatment of withdrawal-related symptoms, acute intervention, and long term therapies designed to reduce likelihood of relapse. Some specialists, primarily those who also have expertise in family medicine or internal medicine, also provide treatment for disease states commonly associated with substance use, such as hepatitis and HIV infection.

Patrick Carnes is an American proponent of the viewpoint that some sexual behavior is an addiction. According to CBS News, he popularized the term sex addiction. He created the International Institute for Trauma and Addiction Professionals (IITAP), as well as numerous addiction treatment facilities, and created the CSAT certification.

<span class="mw-page-title-main">Alcohol detoxification</span> Abrupt cessation of alcohol intake in individuals who have alcohol use disorder

Alcohol detoxification is the abrupt cessation of alcohol intake in individuals that have alcohol use disorder. This process is often coupled with substitution of drugs that have effects similar to the effects of alcohol in order to prevent alcohol withdrawal. When withdrawal does occur, it results in symptoms of varying severity.

<span class="mw-page-title-main">Love addiction</span>

Love addiction is a proposed model of pathological passion-related behavior involving the feeling of falling and being in love. A medical review of related behaviors in animals and humans concluded that current medical evidence does not have definitions or criteria on an addiction model for love addiction, but there are reported similarities to substance dependence, such as euphoria and desire in the stimuli, as well as anhedonia and negative levels of mood when away from the stimuli, intrusive thoughts on it, and disregard for adverse consequences. There has never been a reference to love addiction in the Diagnostic and Statistical Manual of Mental Disorders (DSM), a compendium of mental disorders and diagnostic criteria published by the American Psychiatric Association.

<span class="mw-page-title-main">Nemours Children's Hospital, Delaware</span> Hospital in Delaware, United States

Nemours Children's Hospital, Delaware is a pediatric hospital located in Wilmington, Delaware. It is operated by the Nemours Foundation, a non-profit organization created through the last will and testament of philanthropist Alfred I. du Pont by his widow Jessie Ball duPont in 1936, and dedicated to improving the health of children. Historically, it was referred to as the A. I. duPont Institute for Crippled Children or more simply, the DuPont Institute and provides pediatric specialties and subspecialties to infants, children, teens, and young adults up to age 21.

The Global Appraisal of Individual Needs (GAIN) is a family of evidence-based instruments used to assist clinicians with diagnosis, placement, and treatment planning. The GAIN is used with both adolescents and adults in all kinds of treatment programs, including outpatient, intensive outpatient, partial hospitalization, methadone, short-term residential, long-term residential, therapeutic community, and correctional programs.

<span class="mw-page-title-main">Mark S. Gold</span>

Mark S. Gold is an American physician, professor, author, and researcher on the effects of opioids, cocaine, tobacco, and other drugs as well as food on the brain and behavior. He is married to Janice Finn Gold.

About 1 in 7 Americans suffer from active addiction to a particular substance. Addiction can cause physical, psychological, and emotional harm to those who are affected by it. The American Society of Addiction Medicine defines addiction as "a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences." In the world of psychology and medicine, there are two models that are commonly used in understanding the psychology behind addiction itself. One model is referred to as the disease model of addiction. The disease model suggests that addiction is a diagnosable disease similar to cancer or diabetes. This model attributes addiction to a chemical imbalance in an individual's brain that could be caused by genetics or environmental factors. The second model is the choice model of addiction, which holds that addiction is a result of voluntary actions rather than some dysfunction of the brain. Through this model, addiction is viewed as a choice and is studied through components of the brain such as reward, stress, and memory. Substance addictions relate to drugs, alcohol, and smoking. Process addictions relate to non-substance-related behaviors such as gambling, spending money, sexual activity, gaming, spending time on the internet, and eating.

Community reinforcement approach and family training (CRAFT) is a behavior therapy approach in psychotherapy for treating addiction developed by Robert J. Meyers in the late 1970s. Meyers worked with Nathan Azrin in the early 1970s whilst he was developing his own community reinforcement approach (CRA) which uses operant conditioning techniques to help people learn to reduce the power of their addictions and enjoy healthy living. Meyers adapted CRA to create CRAFT, which he described as CRA that "works through family members." CRAFT combines CRA with family training to equip concerned significant others (CSOs) of addicts with supportive techniques to encourage their loved ones to begin and continue treatment and provides them with defences against addiction's damaging effects on themselves.

David R. Gastfriend is an American psychiatrist, internationally recognized addiction treatment researcher, the former Chief Executive Officer of the Treatment Research Institute (TRI), and current Chief Medical Officer of DynamiCare Health.

Discrimination against drug addicts is a form of discrimination against people who suffer from a drug addiction.

The United States has experienced an increase in the number of people incarcerated that have an opioid addiction. It is estimated that there is around 7 million people incarcerated in the United States. Over half of them meet the Diagnostic and Statistical Manual for Mental Disorders criteria for drug abuse or dependence and only 20% receive treatment. To alleviate the problem, the Department of Corrections has implemented different treatment plans for those who are suffering with an opioid addiction.

Kelly J. Clark is an American physician and psychiatrist known for her work in the fields of substance use disorder, addiction medicine, and addiction psychiatry.

John F. Kelly is an American-based researcher and professor of addiction medicine at Harvard Medical School. He is the Founder and Director of the Massachusetts General Hospital Recovery Research Institute, Associate Director of the MGH Center for Addiction Medicine, and Program Director of the MGH Addiction Recovery Management Service.